1994
DOI: 10.1016/0002-8703(94)90523-1
|View full text |Cite
|
Sign up to set email alerts
|

Early cardiac allograft failure after orthotopic heart transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0
1

Year Published

1999
1999
2014
2014

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(13 citation statements)
references
References 18 publications
0
12
0
1
Order By: Relevance
“…Most of them are concerned with the successful use of MCS in conjunction with RHF [10,11,12,14,15]. Others report the treatment of PGF with LVAD [9,18] or with BVAD [16,17,19,20]. On the basis of an evaluation of more than 200 cases with MCS in our hospital [2,4,5,6,7] the advantages and disadvantages of the individual systems could be proven.…”
Section: Discussionmentioning
confidence: 99%
“…Most of them are concerned with the successful use of MCS in conjunction with RHF [10,11,12,14,15]. Others report the treatment of PGF with LVAD [9,18] or with BVAD [16,17,19,20]. On the basis of an evaluation of more than 200 cases with MCS in our hospital [2,4,5,6,7] the advantages and disadvantages of the individual systems could be proven.…”
Section: Discussionmentioning
confidence: 99%
“…Another limitation is the definition of early graft failure. We used criteria commonly referred to in the literature (6,47), but we defined the time at which early graft failure was diagnosed more restrictively. CONCLUSION Elevated levels of both cTnT and cTnI were found in donors with ongoing impairment of heart function, even when direct inspection and hemodynamic and echocardiographic measurements showed no evidence of impaired heart function.…”
Section: Limitations Of This Studymentioning
confidence: 99%
“…In seeking to understand why endogenous memory CD8 T cells within unprimed mice are unable to mediate cardiac allograft rejection, we realized that the donor grafts in these studies were subjected to minimal cold ischemic storage (0.5 h) prior to transplant, a protocol that is not only clinically unrealistic, but may minimize the activity of early graft infiltrating endogenous memory T cells and maximize the efficacy of tolerance-inducing strategies. Considering the critical role of ischemia-reperfusion injury (IRI) on allograft outcome (18)(19)(20)(21)(22)(23)(24)(25), we tested the impact of increased duration of cold ischemic storage on early endogenous memory CD8 T cell infiltration and functions in cardiac allografts. Our results reveal a direct association between increased duration of cold ischemia and numbers of endogenous memory CD8 T cells in the graft within 48 h of reperfusion.…”
Section: Introductionmentioning
confidence: 99%